Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Bronchoscopy in Septic ARDS with VAP
NCT04553367Phase 2Completed
- Sponsor
- King Abdulaziz Specialist Hospital
- Start
- Jul 2020
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by King Abdulaziz Specialist Hospital. Primary endpoints: Number of patients weaned from the ventilator at 2 weeks and Number of patients discharged from ICU at 2 weeks. Started Jul 2020; status: completed.
Beyond the preview
Go deeper on NCT04553367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04553367.